| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
69,870,000 | 67,536,000 | 62,753,000 | 61,860,000 | 60,530,000 |
| Cost of Revenue
|
-29,369,000 | -28,239,000 | -27,201,000 | -27,560,000 | -27,842,000 |
|
Gross Profit
|
40,499,000 | 39,297,000 | 35,551,000 | 34,300,000 | 32,687,000 |
| Selling, General and Administrative Expenses
|
-17,979,000 | -18,141,000 | -17,910,000 | -19,003,000 | -18,609,000 |
|
Research and Development Expenses
|
-9,050,000 | -8,316,000 | -7,479,000 | -6,775,000 | -6,567,000 |
| Depreciation, Amortization and Depletion
|
-1,423,000 | -1,279,000 | -1,105,000 | -995,000 | -1,062,000 |
| Provision Expense/Write-Back
|
-20,000 | -33,000 | 21,000 | -10,000 | -64,000 |
| Other Income/Expense, Operating
|
778,000 | 964,000 | 996,000 | 860,000 | 663,000 |
|
Operating Income/Expenses
|
-27,694,000 | -26,805,000 | -25,477,000 | -24,918,000 | -24,513,000 |
|
Total Operating Profit/Loss
|
12,805,000 | 12,492,000 | 10,074,000 | 9,382,000 | 8,174,000 |
| Total Net Finance Income/Expense
|
-1,472,000 | -1,290,000 | -965,000 | -937,000 | -1,054,000 |
| Net Investment Income
|
-77,000 | -359,000 | -37,000 | -60,000 | 140,000 |
| Irregular Income/Expenses
|
-732,000 | -670,000 | -104,000 | -430,000 | -29,000 |
|
Other Income/Expense, Non-Operating
|
-17,000 | 156,000 | -3,172,000 | 305,000 | -6,105,000 |
|
Non-Operating Income/Expenses, Total
|
-2,298,000 | -2,163,000 | -4,278,000 | -692,000 | -7,019,000 |
|
Pretax Income
|
10,506,000 | 10,328,000 | 5,797,000 | 8,690,000 | 1,156,000 |
|
Provision for Income Tax
|
653,000 | 242,000 | 218,000 | -1,176,000 | 626,000 |
|
Net Income from Continuing Operations
|
11,160,000 | 10,571,000 | 6,015,000 | 7,514,000 | 1,783,000 |
|
Discontinued Operations
|
11,000 | 22,000 | 8,000 | -12,000 | -143,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
11,171,000 | 10,593,000 | 6,023,000 | 7,502,000 | 1,640,000 |
|
Net Income after Non-Controlling/Minority Interests
|
11,171,000 | 10,593,000 | 6,023,000 | 7,502,000 | 1,640,000 |
|
Net Income Available to Common Stockholders
|
11,171,000 | 10,593,000 | 6,023,000 | 7,502,000 | 1,639,000 |
|
Dilution to Earnings
|
0 | -- | 0 | 0 | 0 |
|
Diluted Net Income Available to Common Stockholders
|
11,171,000 | 10,593,000 | 6,023,000 | 7,502,000 | 1,639,000 |
|
Common Dividend per Share
|
67.40 | 67.10 | 66.70 | 66.30 | 65.90 |
| Basic EPS
|
119.00 | 113.60 | 65.30 | 82.30 | 18.20 |
| Diluted EPS
|
117.30 | 111.70 | 64.30 | 81.40 | 18.00 |
|
Basic Weighted Average Shares Outstanding
|
94,015.65 | 93,229.39 | 92,176.78 | 91,121.03 | 90,266.42 |
|
Diluted Weighted Average Shares Outstanding
|
95,283.95 | 94,867.52 | 93,716.12 | 92,207.38 | 91,226.91 |
|
Reported Normalized Diluted EPS
|
123.10 | 115.90 | 103.30 | 96.20 | 91.30 |
12/31/2022 - 1/7/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade